ESC Professional Premium Access

Fibroblast growth factor-23 is an independent predictor of hospitalization for heart failure and major cardiovascular adverse events in patients undergoing cardiac surgery

Congress Session

About the speaker

Doctor Felix Hofer

Medical University of Vienna, Vienna (Austria)
0 follower

8 more presentations in this session

National Early Warning Score 2 provides independent prognostic information in patients hospitalized with heart failure with preserved ejection fraction

Speaker: Doctor K. Berge (Oslo, NO)

Thumbnail

Introduction of a new scoring tool to identify clinically stable heart failure patients

Speaker: Mr A. Gingele (Maastricht, NL)

Thumbnail

Prognostic value of liver damage assessed by direct bilirubin and skeletal muscle weakness in patients with heart failure

Speaker: Mr T. Noda (Sagamihara, JP)

Thumbnail

A comprehensive study of the incremental prognostic value of novel biomarkers in PARADIGM-HF (Bio-PREDICT-HF)

Speaker: Doctor K. McDowell (Glasgow, GB)

Thumbnail

Alkaline phosphatase and bilirubin combined are a powerful predictor of outcome in patients with heart failure and reduced ejection fraction: an analysis of the ATMOSPHERE and PARADIGM-HF trials

Speaker: Doctor C. Adamson (Glasgow, GB)

Thumbnail

Access the full session

Chronic heart failure - Prognosis and prediction of outcome

Speakers: Doctor F. Hofer, Doctor K. Berge, Mr A. Gingele, Mr T. Noda, Doctor K. McDowell...
Thumbnail

About the event

Image

ESC Congress 2022

26 August - 29 August 2022

Sessions Presentations

This platform is supported by

logo Novo Nordisk